Dr. Rajesh Ponugupati (2016) “EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL”, Journal of Population Therapeutics and Clinical Pharmacology, 23(2), pp. 237–246. doi:10.53555/am143177.